CONCLUSION selleck The growing global interest in stem cell research & therapy mandates development of a robust regulation and oversight along with steps to enhance public knowledge and awareness. Embryonic stem cells should be obtained from embryos remaining from infertility procedures after the embryo’s progenitors have made a decision that they do not wish to preserve them. This decision should be explicitly renewed prior to securing the progenitors?? consent to use the embryos in ES cell research. Persons considering donating their excess embryos for research purposes should be afforded the highest standards of protection for the informed consent and voluntariness of their decision. Special efforts should be made to promote equitable access to the benefits of stem cell research.

Intellectual property regimes for stem cell research should set conditions that do not restrict basic research or encumber future product development. It is essential that there be a public that is educated and informed about the ethical and policy issues raised by stem cell research and its applications. Informed public discussion of these issues should be based on an understanding of the science associated with stem cell research, and it should involve a broad cross-section of society. It is essential for citizens to participate in a full and informed manner in public policy deliberations about the development and application of new technologies that are likely to have significant social impact. The understanding of the science is particularly important Entinostat for discussing ethical and policy issues.

Ideally, scientists should communicate the results of their research in ways that will be readily understandable to a diverse audience, and participate in public discussions nothing related to stem cell research. All ethical principles applying to research must also be ensured in stem cell research: Principles of essentiality, of voluntariness, informed consent and community agreement, of non-exploitation, of privacy and confidentiality, of precaution and risk minimization, of professional competence, of accountability and transparency, of maximization of public interest and distributive justice, of public domain and the principle of totality of responsibility and compliance. Footnotes Source of Support: Nil Conflict of Interest: None declared
Over the last decade, India has become part of globalization of clinical trials. The regulatory changes of 2005 promoted the growth of clinical trials industry. Growing globalization of clinical trials to India and other developing countries has raised ethical concerns.[1,2] The ethical issues reflect the diverse demands of adherence to global ethical guidelines and local practice of compliance to regulations governing clinical trials.